Bio Archives | Health Fitness

Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm

An experimental Ventyx Biosciences drug led to statistically significant reductions in blood levels of a protein that’s an indicator of cardiovascular risk, preliminary Phase 2 results that support this molecule’s approach of addressing what is becoming a competitive inflammation target for heart disease. The data readout also starts the clock on negotiations with a big…

Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic

Admin4 months ago04 mins

Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients with the two subtypes that represent the majority of colorectal cancer cases. The technologies of Cartography Biosciences enable its scientists to find their way to the right targets for…